246 related articles for article (PubMed ID: 26586147)
41. Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics.
Zidan AS; Mokhtar M
J Pharm Sci; 2011 Jun; 100(6):2212-21. PubMed ID: 21259237
[TBL] [Abstract][Full Text] [Related]
42. Mechanical properties, skin permeation and in vivo evaluations of dexibuprofen-loaded emulsion gel for topical delivery.
Jin SG; Yousaf AM; Son MW; Jang SW; Kim DW; Kim JO; Yong CS; Kim JH; Choi HG
Arch Pharm Res; 2015 Feb; 38(2):216-22. PubMed ID: 24988989
[TBL] [Abstract][Full Text] [Related]
43. Quality by design approach to prepare oleoyl alginate derivative and its use in transdermal delivery.
Al-Remawi M; Hamam F; Hamaidi M
Pharm Dev Technol; 2015 Mar; 20(2):227-36. PubMed ID: 24266691
[TBL] [Abstract][Full Text] [Related]
44. In vitro and in vivo assessment of matrix type transdermal therapeutic system of labetalol hydrochloride.
Mittal A; Parmar S; Singh B
Curr Drug Deliv; 2009 Oct; 6(5):511-9. PubMed ID: 19863491
[TBL] [Abstract][Full Text] [Related]
45. SEBS block copolymers as novel materials to design transdermal patches.
Gennari CGM; Quaroni GMG; Creton C; Minghetti P; Cilurzo F
Int J Pharm; 2020 Feb; 575():118975. PubMed ID: 31857184
[TBL] [Abstract][Full Text] [Related]
46. Formulation optimization and characterization of transdermal film of simvastatin by response surface methodology.
Parhi R; Suresh P
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():331-41. PubMed ID: 26478318
[TBL] [Abstract][Full Text] [Related]
47. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
Kumar D; Ali J; Baboota S
Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
[TBL] [Abstract][Full Text] [Related]
48. Enhancement of skin permeation of flurbiprofen via its transdermal patches using isopulegol decanoate (ISO-C10) as an absorption enhancer: pharmacokinetic and pharmacodynamic evaluation.
Chen Y; Quan P; Liu X; Guo W; Song W; Cun D; Wang Z; Fang L
J Pharm Pharmacol; 2015 Sep; 67(9):1232-9. PubMed ID: 25994482
[TBL] [Abstract][Full Text] [Related]
49. Artificial neural network for modeling formulation and drug permeation of topical patches containing diclofenac sodium.
Lefnaoui S; Rebouh S; Bouhedda M; Yahoum MM
Drug Deliv Transl Res; 2020 Feb; 10(1):168-184. PubMed ID: 31485997
[TBL] [Abstract][Full Text] [Related]
50. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
Eur J Pharm Sci; 2014 Feb; 52():86-94. PubMed ID: 24215737
[TBL] [Abstract][Full Text] [Related]
51. Development and evaluation of dexibuprofen formulation with fast onset and prolonged effect.
Choi Y; Min KA; Kim CK
Drug Dev Ind Pharm; 2019 Jun; 45(6):895-904. PubMed ID: 30889990
[TBL] [Abstract][Full Text] [Related]
52. Formulation, in vitro and in vivo evaluation of transdermal patches containing risperidone.
Aggarwal G; Dhawan S; Hari Kumar SL
Drug Dev Ind Pharm; 2013 Jan; 39(1):39-50. PubMed ID: 22335586
[TBL] [Abstract][Full Text] [Related]
53. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
Mittal A; Sara US; Ali A; Mohammed A
Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
[TBL] [Abstract][Full Text] [Related]
54. Ultrasound-assisted transdermal delivery of alendronate for the treatment of osteoporosis.
Li B; Huang G; Ma Z; Qin S
Acta Biochim Pol; 2020 Jun; 67(2):173-179. PubMed ID: 32558528
[TBL] [Abstract][Full Text] [Related]
55. Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation.
Cui H; Quan P; Zhou Z; Fang L
Drug Deliv; 2016 Nov; 23(9):3461-3470. PubMed ID: 27257038
[TBL] [Abstract][Full Text] [Related]
56. Combination of transdermal patches and solid microneedles for improved transdermal delivery of primaquine.
Ananda PWR; Elim D; Zaman HS; Muslimin W; Tunggeng MGR; Permana AD
Int J Pharm; 2021 Nov; 609():121204. PubMed ID: 34662646
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the transdermal permeation behavior of Proterguride from drug in adhesive matrix patches through hairless mouse skin.
Schurad B; Tack J; Lipp R
Drug Dev Ind Pharm; 2005 Jul; 31(6):505-13. PubMed ID: 16109623
[TBL] [Abstract][Full Text] [Related]
58. A QUALITY BY DESIGN APPROACH: FABRICATION, CHARACTERIZATION AND EVALUATION OF OPTIMIZED TRANSDERMAL THERAPEUTIC SYSTEM FOR ANTIRHEUMATIC LORNOXICAM.
Naeem M; Pervaiz F; Nawaz Z; Yousup M; Ali A; Khalid N; Khan JA
Acta Pol Pharm; 2017 Jan; 74(1):249-266. PubMed ID: 29474780
[TBL] [Abstract][Full Text] [Related]
59. Formulation and evaluation of transdermal patches of donepezil.
Madan JR; Argade NS; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(1):95-103. PubMed ID: 25354347
[TBL] [Abstract][Full Text] [Related]
60. Transdermal atenolol releasing system: an approach towards its development.
Gupta SP; Jain SK
J Drug Target; 2006 Nov; 14(9):607-13. PubMed ID: 17090396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
